CMS has announced it will begin reimbursing for four new Q codes effective for claims with dates of service on or after July 1.
The four new codes, with their short description, are:
- Q2041 — Wilate injection
- Q2042 — Hydroxyprogesterone caproate
- Q2043 — Sipuleucel-T auto CD54+
- Q2044 — Belimumab injection
The new codes have an MPFSDB status indicator of E.
CMS also announced it will no longer reimburse for J7184 (Wilate injection) effective for claims with dates of service on or after July 1.
View the CMS transmittal (2207) announcing the HCPCS code changes (pdf).
Related Articles on Coding:
Medicare Designates Four New K Codes for Billing Suction Pumps and Surgical Dressings
ICD-10 Straight Talk: Overview
Drug Code Changes Included in July HCPCS Level II Updates